Ischaemic heart disease in young hypertensive women.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 482245)

Published in Br Heart J on January 01, 1980

Authors

A Mackay, A M Cumming, J J Brown, A F Lever, J I Robertson

Articles cited by this

Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28

The electrocardiogram in population studies. A classification system. Circulation (1960) 11.86

The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ (1962) 10.43

Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80

Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50

EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASE IN A TOTAL COMMUNITY--TECUMSEH, MICHIGAN. Ann Intern Med (1965) 2.63

The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am J Med (1973) 2.50

Malignant hypertension and cigarette smoking. Br Med J (1979) 2.13

Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med (1967) 1.89

The estimation of renin in human plasma. Biochem J (1964) 1.85

Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J (1975) 1.79

Electrocardiographic changes resembling myocardial ischaemia in asymptomatic men with normal coronary arteriograms. Br Heart J (1979) 1.70

Ischaemic heart disease in young women. Br Med J (1974) 1.63

Blood pressure in women taking oral contraceptives. Br Med J (1974) 1.54

Excess smoking in malignant-phase hypertension. Br Med J (1979) 1.38

The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol (1969) 1.25

Value of prolonged recording of blood pressure in assessment of hypertension. Br Heart J (1974) 1.17

Coronary artery disease in young women. JAMA (1974) 0.95

Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries. Am J Cardiol (1977) 0.93

Smoking and renal artery stenosis. Br Med J (1979) 0.82

Maximum treadmill exercise electrocardiography in female patients. Circulation (1974) 0.81

Articles by these authors

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet (1992) 4.18

Captopril in the treatment of clinical hypertension and cardiac failure. Lancet (1979) 3.93

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ (1989) 3.74

Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol (1998) 3.58

Examination of clinical examiners. Lancet (1969) 3.07

Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J (Clin Res Ed) (1983) 2.90

Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74

Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol (1976) 2.25

Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene (2010) 2.11

Medical Investigation of Retinal Vascular Occlusion. Br Med J (1964) 1.93

Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91

Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. J Hypertens (1987) 1.90

Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med (1997) 1.89

Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J (1980) 1.88

The estimation of renin in human plasma. Biochem J (1964) 1.85

Essential hypertension: a disorder of growth with origins in childhood? J Hypertens (1992) 1.85

Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83

Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension (1990) 1.77

Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76

Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens (1986) 1.71

Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71

A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis (1996) 1.70

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun (2001) 1.69

"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69

Captopril: five years on. Br Med J (Clin Res Ed) (1983) 1.68

Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68

Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol (1996) 1.67

Renin and acute renal failure: studies in man. Br Med J (1970) 1.66

Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol (2006) 1.63

Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60

Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60

Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology (1993) 1.60

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol (2006) 1.57

The estimation of renin in plasma by an enzyme kinetic technique. Biochem J (1964) 1.56

Countercurrent exchange between the vasa recta and the loop of Henle. Lancet (1966) 1.52

Salt and hypertension. Lancet (1984) 1.52

Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss. J Neurol (2008) 1.51

MR findings in a patient with Caffey's disease. Pediatr Radiol (1996) 1.49

Psychiatric disturbance leading to potassium depletion, sodium depletion, raised plasma-renin concentration, and secondary hyperaldosteronism. Lancet (1968) 1.49

Purification of pig renin. Biochem J (1966) 1.48

Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension (1991) 1.46

Renin and angiotensin. A survey of some aspects. Postgrad Med J (1966) 1.45

The factor VIII gene intron 1 inversion mutation: prevalence in severe hemophilia A patients in the UK. J Thromb Haemost (2004) 1.44

Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) (1986) 1.44

Detecting environmental change: science and society-perspectives on long-term research and monitoring in the 21st century. Sci Total Environ (2003) 1.43

Persistent mal de debarquement syndrome: a motion-induced subjective disorder of balance. Am J Otolaryngol (1987) 1.41

Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG. Infect Immun (1997) 1.41

Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res (2000) 1.40

Dietary salt and essential hypertension. Lancet (1996) 1.40

Minoxidil in the management of intractable hypertension. Q J Med (1981) 1.39

Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell (2004) 1.38

Excess smoking in malignant-phase hypertension. Br Med J (1979) 1.38

Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins. J Infect Dis (1997) 1.38

Letter: Intravenous labetalol in severe hypertension. Lancet (1975) 1.37

Potent new inhibitors of human renin. Nature (1982) 1.37

Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37

Long-term effects of neonatal sodium restriction on blood pressure. Am J Hypertens (1997) 1.37

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet (1971) 1.37

The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli. Infect Immun (1996) 1.37